The global oncology drugs market is set to reach $474.06 billion by 2030 with a strong CAGR of 11.53%. Key drivers include the increasing cancer cases, treatment advancements, and high investments in R&D. Market segmentation involves therapy, drug class, indication, dosage forms, and distribution channels, with targeted therapy and injectables leading the way. North America dominates due to high cancer prevalence and advanced healthcare infrastructure, with major players like AbbVie, Takeda Pharmaceutical, Roche, Pfizer, and Novartis.

Oncology Drugs Market Surge 2030